Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nutex Health (NUTX) Short-Term Debt issuances (2016 - 2025)

Nutex Health's Short-Term Debt issuances history spans 6 years, with the latest figure at $437000.0 for Q3 2025.

  • For Q3 2025, Short-Term Debt issuances fell 56.3% year-over-year to $437000.0; the TTM value through Dec 2025 reached $5.0 million, up 122.94%, while the annual FY2025 figure was $5.0 million, 122.94% up from the prior year.
  • Short-Term Debt issuances for Q3 2025 was $437000.0 at Nutex Health, down from $742000.0 in the prior quarter.
  • Across five years, Short-Term Debt issuances topped out at $3.9 million in Q1 2025 and bottomed at $89.0 in Q4 2023.
  • The 5-year median for Short-Term Debt issuances is $492474.5 (2022), against an average of $899279.2.
  • The largest annual shift saw Short-Term Debt issuances crashed 99.71% in 2023 before it skyrocketed 1269562.92% in 2024.
  • A 5-year view of Short-Term Debt issuances shows it stood at $320430.0 in 2021, then tumbled by 90.4% to $30765.0 in 2022, then plummeted by 99.71% to $89.0 in 2023, then surged by 1269562.92% to $1.1 million in 2024, then tumbled by 61.33% to $437000.0 in 2025.
  • Per Business Quant, the three most recent readings for NUTX's Short-Term Debt issuances are $437000.0 (Q3 2025), $742000.0 (Q2 2025), and $3.9 million (Q1 2025).